We report the emergence of disseminated infections caused by Blastoschizomyces capitatus in the temperate zone of central Switzerland.
Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp.
Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases.
Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients.
Clinical characteristics of 5 patients with Blastoschizomyces capitatus yeast infection, Switzerland, June 2009-June 2010 * Patient no.
In immunocompromised patients, a prolonged exposure to various environmental factors has led to an increase in the number of infections caused by P lilacinus, Fusarium species, Acremonium species, Trichosporon beigelii, Blastoschizomyces
capitatus, Penicillium species, and other dematiaceous species.
The essential oil of Agastache rugosa and its main constituent estragole showed synergism with ketoconazole against Blastoschizomyces
capitatus (Geotrichum capitatum, Trichosporon capitatum) Sporobolomyces S.
Abstract: Blastoschizomyces capitatus is an emerging fungal pathogen.
Key Words: Blastoschizomyces capitatus, immunocompetent, pneumonia
Blastoschizomyces capitatus is recognized as an emerging fungal pathogen in immunocompromised patients, especially those with underlying hematologic malignancies.
1) The organism was originally known as Trichosporon capitatum and then Geotrichum capitatum, but has been reclassified to the genus Blastoschizomyces.